SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001485003-16-000174
Filing Date
2016-09-22
Accepted
2016-09-22 16:54:04
Documents
1
Period of Report
2016-09-20

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_147457763133880.html 4  
1 FORM 4 wf-form4_147457763133880.xml 4 6100
  Complete submission text file 0001485003-16-000174.txt   7497
Mailing Address C/O ELEVEN BIOTHERAPEUTICS 215 FIRST ST. #400 CAMBRIDGE MA 02142
Business Address
HURLY STEPHEN A (Reporting) CIK: 0001130637 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36296 | Film No.: 161898052

Mailing Address 215 FIRST STREET SUITE 400 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 400 CAMBRIDGE MA 02142 617-871-9911
Eleven Biotherapeutics, Inc. (Issuer) CIK: 0001485003 (see all company filings)

IRS No.: 252025616 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations